Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Sep 3.
Published in final edited form as: Curr Psychopharmacol. 2020;9(2):91–102. doi: 10.2174/2211556009999200416153022

Eating Disorders on College Campuses in the United States: Current Insight on Screening, Prevention, and Treatment

Anne C Grammer 1,*, Ellen E Fitzsimmons-Craft 1, Olivia Laing 1, Bianca De Pietro 1, Denise E Wilfley 1
PMCID: PMC7470246  NIHMSID: NIHMS1623765  PMID: 32905358

Abstract

Background:

Eating disorders are prevalent on college campuses and pose significant risks to student health, well-being, and academic performance. However, few students receive access to evidence-based prevention and treatment.

Objective:

The present review synthesizes the recent literature on ED screening, prevention, and treatment approaches on college campuses in the United States. We provide an overview of ED screening efforts on college campuses, including relevant screening tools, summarize the extant literature on prevention programming, as well psychological and pharmacological treatment approaches, and outline limitations of current programming and provide future directions for research.

Conclusion:

Recent advances in ED screening, prevention, and treatment efforts highlight the importance of early detection and intervention. Innovative approaches to screening and dissemination of evidence-based prevention and treatment programs on college campuses are warranted. Implications for future research are discussed.

Keywords: College students, eating disorders, pharmacotherapy, psychotherapy, screening, treatment, United States

1. INTRODUCTION

An estimated 11% to 17% of females and approximately 4% of males on college campuses in the United States screen positive for clinical ED symptoms [1]. Further, 20% to 67% of college students experience subthreshold ED symptoms [13]. The transition from adolescence to young adulthood is a high-risk period for the development and persistence of EDs and unhealthy weight control behaviors [4, 5]. Indeed, the median age of ED onset (i.e. ages 18–21) [6] coincides with the typical age of college enrollment, and weight-related behavior changes are salient during the college years [5, 7]. Delayed detection and treatment of EDs have negative long-term medical consequences (e.g., bradycardia, gastrointestinal disorders, metabolic syndrome, hypo/hypertension, over-weight/obesity) [811], which may contribute to disease progression and the overall economic burden of EDs [12]. Further, EDs have some of the highest mortality rates of mental health disorders [13] and are associated with impaired education attainment [14] and psychosocial functioning [15], which may significantly impact student quality of life. There is also a burgeoning body of research on the identification of etiological factors involved in EDs (e.g., genome-wide association studies, gut microbiome) [1618]. However, much of this work has focused exclusively on anorexia nervosa (AN), and the application of these findings to precision medicine remains unclear at present.

Despite the prevalence and deleterious effects of EDs, current screening, prevention, and treatment efforts on college campuses in the United States are lacking. One study found that only 20% of college students who positively screen for an ED report receiving treatment in the past year [1]. Further, several challenges preclude implementation of evidence-based ED programming on college campuses, such as understaffing and the rapidly rising student demand for mental health services [19]. Indeed, the average student to counselor ratio is 1731:1, thereby highlighting the limited capacity of counseling centers to deliver effective care [1]. Taken together, these findings underscore the need to implement ED screening, prevention, and treatment on college campuses to expand access to evidence-based care. The present review aims to synthesize the recent literature on ED screening, prevention, and treatment approaches on college campuses. Specifically, we aim to: 1) provide an overview of relevant screening tools to facilitate ED assessment and three prominent screening programs; 2) summarize the extant literature on prevention and psychological and pharmacological treatment approaches, including evidence-based in-person interventions and digital interventions; 3) outline limitations of current programming and provide future directions for research.

2. RELEVANT SCREENING TOOLS

Various self-report screening tools have been utilized to assess ED risk on college campuses (Table 1). Among these screening tools, the Eating Attitudes Test-26 (EAT-26) [20], the Eating Disorder Examination-Questionnaire (EDE-Q) [21], the SCOFF [22], and the Stanford-Washington University Eating Disorder Screen (SWED) [23] are some of the most commonly used assessments in large screening studies on college campuses [24]. These measures have been shown to haveadequate psychometric properties in college populations [1, 23, 25, 26]. Currently, there is a lack of consensus on a preferred screening tool for college populations, as the goals of ED screeners vary considerably. Fitzsimmons-Craft and colleagues note that the goal of screening should drive screener selection [24]. If the goal is to determine if students are at risk for an ED or not, the EAT-26 may be the most inclusive and simple screening tool to use. If there is more interest in examining the frequency of different ED-related behaviors in a student population, the EDE-Q may be a good option. Considering its brevity, the SCOFF could easily be implemented with other health screenings. Finally, the SWED may be the best option for colleges and universities interested in grouping students into ED risk and diagnostic categories.

Table 1.

Common assessments used to screen college students for EDs [2,3].

Questionnaire Construct Assessed Number of Items Strengths Weaknesses
Eating-Attitudes Test-26 (EAT-26) [20] ED attitudes and behaviors 26 Simple to score Time intensive to administer and score due to the large number of items
Eating Disorder Examination- Questionnaire (EDE-Q) [21] Presence and frequency of disordered eating thoughts and behaviors within the past 28 days; 4 subscale scores (eating concern, shape concern, weight concern, dietary restraint) and a global score can be generated 36 Examines both presence of ED psychopathology and frequency of ED behaviors Time intensive to administer and score due to the large number of items
SCOFF [22] Presence of core features of AN and BN 5 Brief and simple to administer and score either orally or in written form Questions may not capture EDs other than AN or BN (e.g., BED)
Stanford-Washington University Eating Disorder Scale (SWED) [23] ED psychopathology, behaviors and impairment within the past 3 months; Categorizes individuals into risk categories (i.e. possible AN, clinical/subclinical ED other than AN, high risk, low risk) 17 Examines both presence of ED psychopathology and frequency of ED behaviors; Assigns individuals to different ED-risk categories More complex scoring procedure than utilizes a computer-based algorithm

3. ONGOING SCREENING EFFORTS ON COLLEGE CAMPUSES

Multiple large-scale studies have aimed to disseminate some of the aforementioned screening tools on college campuses through various recruitment strategies, including population-wide surveys, solicited screenings (e.g., advertising at student health centers), and simple randomization of selected students [24]. However, college surveillance data indicate that only 45% of colleges provide ED screening once per semester or year, and 22% provide year-around ED screening [27]. Screening efforts are crucial in closing the treatment gap because they can mobilize help-seeking behavior by providing students with accurate feedback on their ED risk profile and connecting them to available treatment options. Here, we summarize two research programs focused on ED screening on college campuses (i.e. the Healthy Body Image Program and the Healthy Minds Study). Next, we comment on the availability of ED screening to college students in the “real world,” as offered through the National Eating Disorders Association (NEDA).

3.1. The Healthy Minds Study (HMS)

HMS is a web-based survey that examines mental health and service usage in college students [27, 28]. The survey uses the SCOFF to measure ED symptoms along with other measures that assess the presence of additional mental health diagnoses. The study has a broad reach across many campuses, with over 300 participating schools and around 300,000 respondents. A randomly selected sample of students at each university are invited to participate, and 16% to 29% of selected students typically elect to take the survey [27, 28]. In a 2018–2019 survey, HMS found that 13.5% of women and 6.2% of men screened positive for an ED [27].

3.2. Healthy Body Image (HBI) Program

HBI uses an online platform to identify university students at low risk for, high risk for, or with current subthreshold or threshold ED diagnosis [29, 30]. Based on the clinical profile, students are directed to a tailored, online cognitive-behavioral program or provided with a referral for in-person care as follows: 1) “Low risk” individuals are offered StayingFit, a universal preventive intervention, which targets increased fruit/vegetable consumption, weight/shape concerns, healthy weight management for students with normal weight, and weight loss for students with overweight [31]; 2) “high risk” individuals are offered StudentBodies-Targeted, a targeted preventive intervention, which addresses ED risk and symptom onset [32, 33] (see “Prevention”). Students with a subthreshold or threshold ED other than AN are offered Student Bodies-Eating Disorders (SB-ED), an online cognitive-behavioral guided self-help treatment program that targets symptom progression [34]; 4) Students with possible AN are referred to in-person treatment services on their campus.

HBI was disseminated at 28 universities as part of a randomized controlled trial [30]. Over the course of 3 years, 4,894 students completed the screen, which used the SWED, representing an average of 1.9% of undergraduate females on each campus. About 60% of participating students were indicated to be at high risk for or to have an ED. These rates are higher than the proportion of ED-indicated students in the HMS, which was implemented as a population-level survey, whereas the HBI survey used self-selection recruitment methods (e.g., flyers, social media postings), which appear to have attracted students with elevated levels of eating pathology. Notably, high rates of uptake were demonstrated for students who were offered online interventions within HBI. For example, 83% of those screening positive for a clinical ED, other than AN, who were offered an online intervention began the mobile program, while only 28% of those randomized to receive a referral to usual care sought treatment over the 2-year follow-up period (Fitzsimmons-Craft et al. under review).

3.3. National Eating Disorders Association (NEDA) Screener and the Collegiate Survey Project

NEDA, the leading U.S.-based non-profit organization for eating disorders awareness, offers a web-based ED screener for self-directed assessment of ED symptoms using the SWED. In a recent study that examined the screening results among 71,362 respondents (primarily college-aged women), the majority (86.3%) screened positive for an ED [35]. However, only 3% of those who screened positive for an ED were currently in treatment, thereby demonstrating the great potential for screeners to connect individuals with information about accessing interventions.

Taken together, large-scale studies have demonstrated the feasibility of using a range of screening tools to assess ED risk in college-aged populations. However, studies highlight the need to capitalize on post-screening opportunities in order to link respondents to evidence-based care.

4. PREVENTION

ED prevention programs are effective in mitigating ED risk through early detection and intervention. We summarize the approaches and efficacy of two evidence-based prevention programs that have been used with college women, The Body Project and Student Bodies.

4.1. The Body Project

The Body Project is a dissonance-based ED prevention program for high school and college-aged women that targets two prominent ED risk factors, thin-ideal internalization and body dissatisfaction [36]. The Body Project applies persuasion principles to facilitate cognitive conflict between endorsed ED attitudes and criticism of the thin-ideal. Consequently, dissonance is posited to reduce subscription to ED attitudes and subsequent engagement in ED behaviors [36]. Recent meta-analytic findings indicate that dissonance-based ED programs demonstrate more robust effects than non-active and active controls [37]. Specifically, participation in The Body Project is associated with short- and long-term reductions in core ED risk factors (e.g., thin-ideal internalization, body dissatisfaction, negative affect) [3840], ED symptoms (e.g., binge eating and purging) [3941], and the prevention of future onset of EDs and obesity [42]. Further, participation in the Body Project is associated with less frequent use of mental-health services, demonstrating the effectiveness of connecting students with early access to care [42].

Barriers to the dissemination of the Body Project on college campuses include the lack of available clinicians to deliver the prevention program, and even when clinicians are available, there may be high turnover [43]. To address these limitations, Stice and colleagues developed an internet intervention, eBody Project, which is a 3-week, standalone intervention that does not involve monitoring from a clinician. Pilot data indicate that eBody Project demonstrated similar effect sizes in reductions in ED risk factors and symptoms compared to the group-based version [43]. However, these effects were more robust in the group-based intervention at 1- and 2-year follow-up [44]. Additionally, recent data suggest that ED onset over 4-year follow-up was marginally lower among students who received an in-person, peer-led version of the Body Project compared to students who received the eBody Project intervention [45].

4.2. Student Bodies-targeted

The limited long-term effects of eBody Project may suggest the need to include clinicians as part of digital programs to monitor symptoms, encourage engagement, and tailor the intervention for non-responders. Student Bodies-targeted is an online, cognitive-behavioral prevention program for students at high risk for EDs. Students complete 8 online modules that focus on addressing shape and weight concerns, improving body image and healthy weight regulation, reducing ED symptoms, and providing psychoeducation on EDs [33]. Students are also asked to engage in therapist-monitored discussion forums in order to reinforce the weekly material. Results from RCTs indicate that Student Bodies-targeted is associated with 2-year reductions in ED risk factors (e.g., shape and weight concerns) and decreases the risk of ED onset in some high risk participants [32, 33]. Among students with comorbid depressive symptoms and ED pathology, Student Bodies-targeted was more efficacious in addressing depressive symptomology than control [46]. Prevention programs, such as The Body Project and Student Bodies-targeted, are promising methods for identifying students at high risk for EDs and connecting them to further assessment and treatment.

5. TREATMENT

5.1. In-person Psychological Interventions

Significant research advances on treatments for EDs have been made in recent years [47], and psychological treatments are considered primary treatments for EDs [48]. Various international clinical guidelines recommend individual or guided self-help cognitive behavioral therapy (CBT), which targets cognitions and behaviors that maintain an ED, as an evidenced-based treatment for adults with bulimia nervosa (BN), binge eating disorder (BED), and subclinical BN and BED [48]. National guidelines also recommend interpersonal psychotherapy (IPT), which targets the interpersonal context that contributes to the development and maintenance of EDs, as an evidence-based treatment for BN/BED [49]. Indeed, CBT and IPT demonstrate equivalent long-term improvements in binge eating [50]. Conversely, meta-analytic findings have not identified a well-supported evidence-based psychological treatment for adults with AN [5153]. Research in pediatric populations suggests that family-based treatment for AN (FBT), which harnesses family support in ED recovery, is a leading evidence-based psychological treatment for children and adolescents with AN [5456], and this approach has also been adapted for young adults (ages 16–25) [57, 58]. Given that many students still dependent on their parents during the transition to adulthood, FBT adapted for transition age youth (FBT-TAY) may be a viable treatment option for college students with AN [58]. Preliminary findings from the first open trial [58] suggest that FBT-TAY is acceptable to young adults with AN, as evidenced by preferential selection of FBT-TAY over treatment as usual by approximately 70% of the participants. Further, participants demonstrated improvements in ED symptoms and achieved weight restoration following treatment and follow-up. These preliminary findings suggest that FBT-TAY may be a promising treatment option for transition age youth with AN. However, rigorous RCTs are needed to assess the efficacy in college populations.

Despite the promising body of research on treatment approaches, the implementation and dissemination of evidence-based psychological treatments on college campuses is a significant challenge [59]. Importantly, in one report, 60% of surveyed university college counseling centers reported offering year-round access to a counselor specializing in EDs, demonstrating the challenge many universities face in offering evidence-based treatment for EDs to the many students in need [60]. Further, perceived barriers such as stigma, the time-intensive nature of in-person interventions, and the financial costs of treatment may deter student engagement with in-person care [59, 61]. Given these limitations, there is a dire need to develop innovative strategies in order to increase access to treatment on college campuses [62].

5.2. Digital Psychological Interventions

Digital interventions may represent one viable solution for maximizing access to care and reducing the burden associated with in-person interventions. As summarized by a recent review of meta-analytic findings on mental health digital programs [63], digital programs for EDs are effective in reducing ED symptoms, with effect sizes in the small to moderate range. A common theme among the reviewed studies was the use of internet-based, CBT guided-self-help (iCBT). Evidence suggests that iCBT is associated with reductions in BN and BED symptoms, including abstinence from binge eating and purging at post-treatment and follow-up [6466]. Moreover, some [6769] but not all [70] studies found that iCBT sustains these improvements more than bibliotherapy [69] or waitlist control [6769].

Overall, digital ED programs demonstrate improvements in ED symptoms, with evidence supporting iCBT. However, intervention engagement remains a significant challenge [71]. Future research is needed to develop strategies that promote continued engagement with digital treatment programs. Future work should investigate whether tailored interventions that further tailor treatment according to an individual’s risk profile (e.g., symptom severity, demographics) or that utilize sensor detectors to provide momentary feedback and intervention (e.g., just in time adaptive interventions) may address the problem of intervention engagement.

5.3. Pharmacological Treatment

Psychological treatment, including in-person and guided self-help, is considered first-line treatment for EDs according to both international and national guidelines [48, 72]. However, given the chronicity of EDs, psychotropic medications are often used clinically as part of multimodal approaches to ED treatment [73]. We review the extant literature on the efficacy of pharmacological treatments for EDs.

For the treatment of AN, a series of RCTs identified antidepressants and atypical antipsychotics as the most investigated pharmacological interventions [74]. Clinically, these medications are used to reduce the prevalence of depression, anxiety, and obsessive-compulsive behaviors and to facilitate weight restoration [75]. However, there is a lack of empirical evidence that weight gain occurs; and while psychiatric symptoms may reduce slightly, there is minimal impact on symptoms of AN specifically [76]. To date, the efficacy of pharmacotherapy for AN is inconclusive, and rigorous RCTs are needed to further evaluate their benefit to treatment [74].

For the treatment of BN and BED, only two psychotropic medications (i.e. fluoxetine for BN and lisdexamfetamine for BED) have been approved by US and international regulatory boards [77]. Findings from meta-analyses and reviews indicate that both medications have a good benefit-risk ratio [78] and result in short-term improvements in core ED psychopathology (e.g., bingeing and purging) compared to placebo [7981]. However, there is a paucity of data to support their long-term efficacy beyond active treatment periods [8285]. Findings from the longest maintenance trial of fluoxetine indicate that continued use of fluoxetine following an open-label trial is associated with lower relapse rate compared to placebo at 3-month follow-up [83]. However, relapse rates did not differ at 6- and 12-month follow-up. Only one study has examined the longer-term effects of lisdexamfetamine for moderate to severe BED. Similarly, results indicated that those who continued to take lisdexamfetamine over 6 months were 11 times less likely to relapse compared to placebo. Longer follow-up periods are warranted to evaluate the long-term efficacy of pharmacotherapy for BN and BED.

Few RCTs have compared fluoxetine and lisdexamfetamine to psychological interventions. Extant trials on BN and BED indicate that combined psychotherapy and pharmacotherapy are only superior compared to pharmacotherapy treatment alone but not compared to psychotherapy alone [79, 86, 87]. Evidence also suggests that individual CBT results in greater reductions in binge eating frequency [88] and abstinence from binge eating up at 2-year follow-up compared to drug alone [89]. Thus, pharmacological treatment may demonstrate modest improvements in ED symptoms when used as part of a multimodal approach to care. More data are needed to evaluate long-term improvements in ED symptoms and prevention of relapse. Further, given that these trials were conducted in adult samples, future research should also evaluate the safety and efficacy of pharmacological interventions in college-aged populations.

6. DISCUSSION

Considerable efforts have been made to reduce the prevalence of EDs on college campuses through implementation and dissemination of evidence-based screening, prevention, and treatment. However, we have identified several limitations of extant programming that warrant future research. Evidence supports the feasibility of using a range of screening tools to assess ED risk among college students. However, campuses seldom implement screening programs, and few screeners directly connect students with ED prevention and treatment programs. Future research should prioritize streamlining the process from screening to intervention in order to close the treatment gap. ED prevention programs are effective in mitigating ED risk through early detection and intervention and may offset the costs of treatment. The cost-effectiveness of prevention programs should be evaluated in order to make recommendations to college counseling centers and stakeholders regarding their wide-scale dissemination. Moreover, although considerable research has been dedicated to the evaluation of evidence-based treatment approaches, dissemination is limited. Digital programs may be a viable solution to increasing access to care on a population level, although sustained engagement can be a challenge, which future research will need to address. Further, given the dearth of data on pharmacological treatments in college populations, it would be useful for future studies to specifically examine potential efficacy of pharmacotherapy in college-age populations. Last, as relevant etiological factors are identified as being involved in the pathophysiology of EDs, future research should explore the use of precision medicine approaches to treatment.

CONCLUSION

EDs are serious public health problems that affect a significant proportion of college students. Recent advances in screening, prevention, and treatment efforts are promising and demonstrate the effectiveness of early detection and intervention. Future research is needed to investigate how to invest college campuses and stakeholders in population-level approaches to prevention and treatment.

FUNDING

This work was supported by R01 MH100455 and K08 MH120341 from the National Institute of Mental Health as well as T32HL130357 from the National Heart, Lung, and Blood Institute.

Footnotes

Publisher's Disclaimer: DISCLAIMER: The above article has been published in Epub (ahead of print) on the basis of the materials provided by the author. The Editorial Department reserves the right to make minor modifications for further improvement of the manuscript.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

REFERENCES

  • [1].Eisenberg D, Nicklett EJ, Roeder K, Kirz NE. Eating disorder symptoms among college students: prevalence, persistence, correlates, and treatment-seeking. J Am Coll Health 2011; 59(8): 700–7. 10.1080/07448481.2010.546461 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Hoerr SL, Bokram R, Lugo B, Bivins T, Keast DR. Risk for disordered eating relates to both gender and ethnicity for college students. J Am Coll Nutr 2002; 21(4): 307–14. 10.1080/07315724.2002.10719228 [DOI] [PubMed] [Google Scholar]
  • [3].Lipson SK, Sonneville KR. Eating disorder symptoms among undergraduate and graduate students at 12 U.S. colleges and universities. Eat Behav 2017; 24: 81–8. 10.1016/j.eatbeh.2016.12.003 [DOI] [PubMed] [Google Scholar]
  • [4].Goldschmidt AB, Wall MM, Zhang J, Loth KA, Neumark-Sztainer D. Overeating and binge eating in emerging adulthood: 10-year stability and risk factors. Dev Psychol 2016; 52(3): 475–83. 10.1037/dev0000086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Nelson MC, Story M, Larson NI, Neumark-Sztainer D, Lytle LA. Emerging adulthood and college-aged youth: an overlooked age for weight-related behavior change. Obesity (Silver Spring) 2008; 16(10): 2205–11. 10.1038/oby.2008.365 [DOI] [PubMed] [Google Scholar]
  • [6].Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biol Psychiatry 2007; 61(3): 348–58. 10.1016/j.biopsych.2006.03.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Racette SB, Deusinger SS, Strube MJ, Highstein GR, Deusinger RH. Changes in weight and health behaviors from freshman through senior year of college. J Nutr Educ Behav 2008; 40(1): 39–42. 10.1016/jjneb.2007.01.001 [DOI] [PubMed] [Google Scholar]
  • [8].Westmoreland P, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa and bulimia. Am J Med 2016; 129(1): 30–7. 10.1016/j.amjmed.2015.06.031 [DOI] [PubMed] [Google Scholar]
  • [9].Mehler P, Birmingham L, Crow S, Jahraus J. Medical complications of eating disorders In: Grilo C, Mitchell J, Ed. The treatment of eating disorders: a clinical handbook. New York, NY: Guilford Press; 2010. pp. 66–80. [Google Scholar]
  • [10].Mitchell JE. Medical comorbidity and medical complications associated with binge-eating disorder. Int J Eat Disord 2016; 49(3): 319–23. 10.1002/eat.22452 [DOI] [PubMed] [Google Scholar]
  • [11].McClain CJ, Humphries LL, Hill KK, Nickl NJ. Gastrointestinal and nutritional aspects of eating disorders. J Am Coll Nutr 1993; 12(4): 466–74. 10.1080/07315724.1993.10718337 [DOI] [PubMed] [Google Scholar]
  • [12].Samnaliev M, Noh HL, Sonneville KR, Austin SB. The economic burden of eating disorders and related mental health comorbidities: an exploratory analysis using the U.S. medical expenditures panel survey. Prev Med Rep 2014; 2: 32–4. 10.1016/j.pmedr.2014.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry 2011; 68(7): 724–31. 10.1001/archgenpsychiatry.2011.74 [DOI] [PubMed] [Google Scholar]
  • [14].Maxwell M, Thornton LM, Root TL, et al. Life beyond the eating disorder: education, relationships, and reproduction. Int J Eat Disord 2011; 44(3): 225–32. 10.1002/eat.20804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Bardone-Cone AM, Harney MB, Maldonado CR, et al. Defining recovery from an eating disorder: conceptualization, validation, and examination of psychosocial functioning and psychiatric comorbidity. Behav Res Ther 2010; 48(3): 194–202. 10.1016/j.brat.2009.11.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Breithaupt L, Hübel C, Bulik CM. Updates on genome-wide association findings in eating disorders and future application to precision medicine. Curr Neuropharmacol 2018; 16(8): 1102–10. 10.2174/1570159X16666180222163450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Duncan L, Yilmaz Z, Gaspar H, et al. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am J Psychiatry. 2017; 174(9): 850–8. 10.1176/appi.ajp.2017.16121402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Seitz J, Trinh S, Herpertz-Dahlmann B. The microbiome and eating disorders. Psychiatr Clin North Am 2019; 42(1): 93–103. 10.1016/j.psc.2018.10.004 [DOI] [PubMed] [Google Scholar]
  • [19].Eisenberg D, Hunt J, Speer N. Help seeking for mental health on college campuses: review of evidence and next steps for research and practice. Harv Rev Psychiatry 2012; 20(4): 222–32. 10.3109/10673229.2012.712839 [DOI] [PubMed] [Google Scholar]
  • [20].Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med 1982; 12(4): 871–8. 10.1017/S0033291700049163 [DOI] [PubMed] [Google Scholar]
  • [21].Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord 1994; 16(4): 363–70. [PubMed] [Google Scholar]
  • [22].Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ 1999; 319(7223): 1467–8. 10.1136/bmj.319.7223.1467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Graham AK, Trockel M, Weisman H, et al. A screening tool for detecting eating disorder risk and diagnostic symptoms among college-age women. J Am Coll Health 2019; 67(4): 357–66. 10.1080/07448481.2018.1483936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Fitzsimmons-Craft EE, Karam AM, Monterubio GE, Taylor CB, Wilfley DE. Screening for eating disorders on college campuses: a review of the recent literature. Curr Psychiatry Rep 2019; 21(10): 101 10.1007/s11920-019-1093-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Kirk G, Singh K, Getz H. Risk of eating disorders among female college athletes and nonathletes. J Coll Couns 2001; 4(2): 122–32. 10.1002/j.2161-1882.2001.tb00192.x [DOI] [Google Scholar]
  • [26].Luce KH, Crowther JH, Pole M. Eating disorder examination questionnaire (EDE-Q): norms for undergraduate women. Int J Eat Disord 2008; 41(3): 273–6. 10.1002/eat.20504 [DOI] [PubMed] [Google Scholar]
  • [27].Eisenberg D, Ketchen Lipson S. The healthy minds study, 2019. Available from: https://healthymindsnetwork.org/wp-content/uploads/2019/09/HMS_national-2018-19.pdf. [Accessed 2020 Mar 5].
  • [28].Eisenberg D, Ketchen Lipson S. The healthy minds study [Internet]. 2014. Available from: https://healthymindsnetwork.org/wp-content/uploads/2019/04/HMS_national_DataReport_2014.pdf
  • [29].Fitzsimmons-Craft EE, Firebaugh M-L, Graham AK, et al. State-wide university implementation of an online platform for eating disorders screening and intervention. Psychol Serv 2019; 16(2): 239–49. 10.1037/ser0000264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Fitzsimmons-Craft EE, Balantekin KN, Eichen DM, et al. Screening and offering online programs for eating disorders: reach, pathology, and differences across eating disorder status groups at 28 U.S. universities. Int J Eat Disord 2019; 52(10): 1125–36. 10.1002/eat.23134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Taylor CB, Taylor K, Jones M, et al. Obesity prevention in defined (high school) populations. Int J Obes Suppl 2012; 2(Suppl. 1): S30–2. 10.1038/ijosup.2012.8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Beintner I, Jacobi C, Taylor CB. Effects of an Internet-based prevention programme for eating disorders in the USA and Germany-a meta-analytic review. Eur Eat Disord Rev 2012; 20(1): 1–8. 10.1002/erv.1130 [DOI] [PubMed] [Google Scholar]
  • [33].Taylor CB, Bryson S, Luce KH, et al. Prevention of eating disorders in at-risk college-age women. Arch Gen Psychiatry 2006; 63(8): 881–8. 10.1001/archpsyc.63.8.881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Jacobi C, Völker U, Trockel MT, Taylor CB. Effects of an internet-based intervention for subthreshold eating disorders: a randomized controlled trial. Behav Res Ther 2012; 50(2): 93–9. 10.1016/j.brat.2011.09.013 [DOI] [PubMed] [Google Scholar]
  • [35].Fitzsimmons-Craft EE, Balantekin KN, Graham AK, et al. Results of disseminating an online screen for eating disorders across the U.S.: reach, respondent characteristics, and unmet treatment need. Int J Eat Disord 2019; 52(6): 721–9. 10.1002/eat.23043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Stice E, Mazotti L, Weibel D, Agras WS. Dissonance prevention program decreases thin-ideal internalization, body dissatisfaction, dieting, negative affect, and bulimic symptoms: a preliminary experiment. Int J Eat Disord 2000; 27(2): 206–17. [DOI] [PubMed] [Google Scholar]
  • [37].Stice E, Marti CN, Shaw H, Rohde P. Meta-analytic review of dissonance-based eating disorder prevention programs: intervention, participant, and facilitator features that predict larger effects. Clin Psychol Rev 2019; 70: 91–107. 10.1016/j.cpr.2019.04.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Stice E, Butryn ML, Rohde P, Shaw H, Marti CN. An effectiveness trial of a new enhanced dissonance eating disorder prevention program among female college students. Behav Res Ther 2013; 51(12): 862–71. 10.1016/j.brat.2013.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Stice E, Rohde P, Butryn ML, Shaw H, Marti CN. Effectiveness trial of a selective dissonance-based eating disorder prevention program with female college students: effects at 2- and 3-year follow-up. Behav Res Ther 2015; 71: 20–6. 10.1016/j.brat.2015.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Stice E, Trost A, Chase A. Healthy weight control and dissonance-based eating disorder prevention programs: results from a controlled trial. Int J Eat Disord 2003; 33(1): 10–21. 10.1002/eat.10109 [DOI] [PubMed] [Google Scholar]
  • [41].Stice E, Rohde P, Shaw H, Gau J. An effectiveness trial of a selected dissonance-based eating disorder prevention program for female high school students: long-term effects. J Consult Clin Psychol 2011; 79(4): 500–8. 10.1037/a0024351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Stice E, Shaw H, Burton E, Wade E. Dissonance and healthy weight eating disorder prevention programs: a randomized efficacy trial. J Consult Clin Psychol 2006; 74(2): 263–75. 10.1037/0022-006X.74.2.263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Stice E, Rohde P, Durant S, Shaw H. A preliminary trial of a prototype internet dissonance-based eating disorder prevention program for young women with body image concerns. J Consult Clin Psychol 2012; 80(5): 907–16. 10.1037/a0028016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Stice E, Durant S, Rohde P, Shaw H. Effects of a prototype internet dissonance-based eating disorder prevention program at 1- and 2-year follow-up. Health Psychol 2014; 33(12): 1558–67. 10.1037/hea0000090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Stice E, Rohde P, Shaw H, Gau JM. Clinician-led, peer-led, and internet-delivered dissonance-based eating disorder prevention programs: effectiveness of these delivery modalities through 4-year follow-up. J Consult Clin Psychol 2017; 85(9): 883–95. 10.1037/ccp0000493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Taylor CB, Kass AE, Trockel M, et al. Reducing eating disorder onset in a very high risk sample with significant comorbid depression: a randomized controlled trial. J Consult Clin Psychol 2016; 84(5): 402–14. 10.1037/ccp0000077 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Davis LE, Attia E. Recent advances in therapies for eating disorders. F1000 Res 2019; 8: 8 10.12688/f1000research.19847.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Overview | Eating disorders: recognition and treatment | Guidance | NICE [Internet]. Nice.org.uk. 2020. [cited 3 March 2020]. Available from: https://www.nice.org.uk/guidance/ng69
  • [49].Eating disorders and obesity | Society of Clinical Psychology [Internet]. Div12.org. 2016. [cited 5 March 2020]. Available from: https://www.div12.org/diagnosis/eating-disorders-and-obesity/
  • [50].Wilfley DE, Welch RR, Stein RI, et al. A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 2002; 59(8): 713–21. 10.1001/archpsyc.59.8.713 [DOI] [PubMed] [Google Scholar]
  • [51].Murray SB, Quintana DS, Loeb KL, Griffiths S, Le Grange D. Treatment outcomes for anorexia nervosa: a systematic review and meta-analysis of randomized controlled trials. Psychol Med 2019; 49(4): 535–44. 10.1017/S0033291718002088 [DOI] [PubMed] [Google Scholar]
  • [52].Watson HJ, Bulik CM. Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions. Psychol Med 2013; 43(12): 2477–500. 10.1017/S0033291712002620 [DOI] [PubMed] [Google Scholar]
  • [53].Zeeck A, Herpertz-Dahlmann B, Friederich H-C, et al. Psychotherapeutic treatment for anorexia nervosa: a systematic review and network meta-analysis. Front Psychiatry 2018; 9: 158 10.3389/fpsyt.2018.00158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Lock J An update on evidence-based psychosocial treatments for eating disorders in children and adolescents. J Clin Child Adolesc Psychol 2015; 44(5): 707–21. 10.1080/15374416.2014.971458 [DOI] [PubMed] [Google Scholar]
  • [55].Lock J, Agras WS, Bryson S, Kraemer HC. A comparison of short- and long-term family therapy for adolescent anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2005; 44(7): 632–9. 10.1097/01.chi.0000161647.82775.0a [DOI] [PubMed] [Google Scholar]
  • [56].Lock J, Le Grange D, Agras WS, Moye A, Bryson SW, Jo B. Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Arch Gen Psychiatry 2010; 67(10): 1025–32. 10.1001/archgenpsychiatry.2010.128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [57].Dimitropoulos G, Freeman VE, Allemang B, et al. Family-based treatment with transition age youth with anorexia nervosa: a qualitative summary of application in clinical practice. J Eat Disord 2015; 3(1): 1 10.1186/s40337-015-0037-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Dimitropoulos G, Landers AL, Freeman V, Novick J, Garber A, Le Grange D. Open trial of family-based treatment of anorexia nervosa for transition age youth. J Can Acad Child Adolesc Psychiatry 2018; 27(1): 50–61. [PMC free article] [PubMed] [Google Scholar]
  • [59].Kazdin AE, Fitzsimmons-Craft EE, Wilfley DE. Addressing critical gaps in the treatment of eating disorders. Int J Eat Disord 2017; 50(3): 170–89. 10.1002/eat.22670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Collegiate Survey Project. Eating disorders on the college campus [Internet]. National Eating Disorders Association; 2013. Available from: https://www.nationaleatingdisorders.org/sites/default/files/CollegeSurvey/CollegiateSurveyProject.pdf
  • [61].Ali K, Farrer L, Fassnacht DB, Gulliver A, Bauer S, Griffiths KM. Perceived barriers and facilitators towards help-seeking for eating disorders: a systematic review. Int J Eat Disord 2017; 50(1): 9–21. 10.1002/eat.22598 [DOI] [PubMed] [Google Scholar]
  • [62].Wilfley DE, Agras WS, Taylor CB. Reducing the burden of eating disorders: a model for population-based prevention and treatment for university and college campuses. Int J Eat Disord 2013; 46(5): 529–32. 10.1002/eat.22117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Taylor CB, Graham AK, Flatt RE, Waldherr K, Fitz-simmons-Craft EE. Current state of scientific evidence on internet-based interventions for the treatment of depression, anxiety, eating disorders, and substance abuse: an overview of systematic reviews and meta-analyses. Eur J Public Health. Forthcoming 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Fairburn CG, Murphy R. Treating eating disorders using the internet. Curr Opin Psychiatry 2015; 28(6): 461–7. 10.1097/YCO.0000000000000195 [DOI] [PubMed] [Google Scholar]
  • [65].Loucas CE, Fairburn CG, Whittington C, Pennant ME, Stockton S, Kendall T. E-therapy in the treatment and prevention of eating disorders: a systematic review and meta-analysis. Behav Res Ther 2014; 63: 122–31. 10.1016/j.brat.2014.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Pittock A, Hodges L, Lawrie SM. The effectiveness of internet-delivered cognitive behavioural therapy for those with bulimic symptoms: a systematic review : a review of iCBT treatment for bulimic symptoms. BMC Res Notes 2018; 11(1): 748 10.1186/s13104-018-3843-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Sánchez-Ortiz VC, Munro C, Stahl D, et al. A randomized controlled trial of internet-based cognitive-behavioural therapy for bulimia nervosa or related disorders in a student population. Psychol Med 2011; 41(2): 407–17. 10.1017/S0033291710000711 [DOI] [PubMed] [Google Scholar]
  • [68].Carrard I, Crépin C, Rouget P, Lam T, Golay A, Van der Linden M. Randomised controlled trial of a guided self-help treatment on the internet for binge eating disorder. Behav Res Ther 2011; 49(8): 482–91. 10.1016/j.brat.2011.05.004 [DOI] [PubMed] [Google Scholar]
  • [69].Ruwaard J, Lange A, Broeksteeg J, et al. Online cognitive-behavioural treatment of bulimic symptoms: a randomized controlled trial. Clin Psychol Psychother 2013; 20(4): 308–18. 10.1002/cpp.1767 [DOI] [PubMed] [Google Scholar]
  • [70].Wagner G, Penelo E, Wanner C, et al. Internet-delivered cognitive-behavioural therapy v. conventional guided self-help for bulimia nervosa: long-term evaluation of a randomised controlled trial. Br J Psychiatry 2013; 202(2): 135–41. 10.1192/bjp.bp.111.098582 [DOI] [PubMed] [Google Scholar]
  • [71].Linardon J, Hindle A, Brennan L. Dropout from cognitive-behavioral therapy for eating disorders: a meta-analysis of randomized, controlled trials. Int J Eat Disord 2018; 51(5): 381–91. 10.1002/eat.22850 [DOI] [PubMed] [Google Scholar]
  • [72].Hilbert A, Hoek HW, Schmidt R. Evidence-based clinical guidelines for eating disorders: international comparison. Curr Opin Psychiatry 2017; 30(6): 423–37. 10.1097/YCO.0000000000000360 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Wonderlich S, Mitchell JE, Crosby RD, et al. Minimizing and treating chronicity in the eating disorders: a clinical overview. Int J Eat Disord 2012; 45(4): 467–75. 10.1002/eat.20978 [DOI] [PubMed] [Google Scholar]
  • [74].Bulik CM, Berkman ND, Brownley KA, Sedway JA, Lohr KN. Anorexia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007; 40(4): 310–20. 10.1002/eat.20367 [DOI] [PubMed] [Google Scholar]
  • [75].Marvanova M, Gramith K. Role of antidepressants in the treatment of adults with anorexia nervosa. Ment Health Clin 2018; 8(3): 127–37. 10.9740/mhc.2018.05.127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Attia E, Schroeder L. Pharmacologic treatment of anorexia nervosa: where do we go from here? Int J Eat Disord 2005; 37(Suppl.): S60–3. 10.1002/eat.20133 [DOI] [PubMed] [Google Scholar]
  • [77].Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force on Eating Disorders. World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychia 2011; 12(6): 400–43. 10.3109/15622975.2011.602720 [DOI] [PubMed] [Google Scholar]
  • [78].Bello NT, Yeomans BL. Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder. Expert Opin Drug Saf 2018; 17(1): 17–23. 10.1080/14740338.2018.1395854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Grilo CM, Reas DL, Mitchell JE. Combining pharmacological and psychological treatments for binge eating disorder: current status, limitations, and future directions. Curr Psychiatry Rep 2016; 18(6): 55 10.1007/s11920-016-0696-z [DOI] [PubMed] [Google Scholar]
  • [80].McElroy SL, Guerdjikova AI, Mori N, Keck PE Jr. Psychopharmacologic treatment of eating disorders: emerging findings. Curr Psychiatry Rep 2015; 17(5): 35 10.1007/s11920-015-0573-1 [DOI] [PubMed] [Google Scholar]
  • [81].Reas DL, Grilo CM. Current and emerging drug treatments for binge eating disorder. Expert Opin Emerg Drugs 2014; 19(1): 99–142. 10.1517/14728214.2014.879291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH. Fluoxetine bulimia nervosa research group, long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995; 166(5): 660–6. 10.1192/bjp.166.5.660 [DOI] [PubMed] [Google Scholar]
  • [83].Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry 2002; 159(1): 96–102. 10.1176/appi.ajp.159.1.96 [DOI] [PubMed] [Google Scholar]
  • [84].Hudson JI, McElroy SL, Ferreira-Cornwell MC, Radewonuk J, Gasior M. Efficacy of lisdexamfetamine in adults with moderate to severe binge eating disorder: a randomized clinical trial. JAMA Psychiatry 2017; 74(9): 903–10. 10.1001/jamapsychiatry.2017.1889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Wilfley DE, Fitzsimmons-Craft EE, Eichen DM. Binge-eating disorder in adults. Ann Intern Med 2017; 166(3): 230–1. 10.7326/L16-0622 [DOI] [PubMed] [Google Scholar]
  • [86].Goldbloom DS, Olmsted M, Davis R, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther 1997; 35(9): 803–11. 10.1016/S0005-7967(97)00041-7 [DOI] [PubMed] [Google Scholar]
  • [87].Grilo CM, Crosby RD, Wilson GT, Masheb RM. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder. J Consult Clin Psychol 2012; 80(6): 1108–13. 10.1037/a0030061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [88].Devlin MJ, Goldfein JA, Petkova E, et al. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 2005; 13(6): 1077–88. 10.1038/oby.2005.126 [DOI] [PubMed] [Google Scholar]
  • [89].Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. Obesity (Silver Spring) 2007; 15(7): 1702–9. 10.1038/oby.2007.203 [DOI] [PubMed] [Google Scholar]

RESOURCES